Jeffrey H. Meyer is a scientist and professor working with mood and anxiety disorders using neuroimaging at the Department of Psychiatry, University of Toronto.
[1] Meyer has experience in working with positron emission tomography, including the use of [11C]DASB, [11C]harmine, [18F]FEPPA, [18F]setoperone, [11C]raclopride, [18F]SynVesT1, and [11C]SL25.1188 radioligands to examine neuropsychiatric disorders.
His work primarily uses neuroimaging to study psychiatric illnesses, complemented by preclinical approaches to investigate related biomarkers.
Meyer has also led early-phase trials testing novel therapeutics targeting pathological markers of depression and has explored peripheral biomarkers linked to mood disorders.
Additionally, he has developed natural health products aimed at alleviating depressive symptoms, particularly during early postpartum and perimenopause.